Edwards Lifesciences Aktie
WKN: 936853 / ISIN: US28176E1082
|
30.10.2025 22:08:55
|
Edwards Lifesciences Corp. Q3 Profit Decreases, But Beats Estimates
(RTTNews) - Edwards Lifesciences Corp. (EW) reported earnings for third quarter that Decreased from the same period last year but beat the Street estimates.
The company's earnings came in at $292.3 million, or $0.50 per share. This compares with $362.1 million, or $0.61 per share, last year.
Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $389.9 million or $0.67 per share for the period.
Analysts on average had expected the company to earn $0.59 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 14.7% to $1.553 billion from $1.354 billion last year.
Edwards Lifesciences Corp. earnings at a glance (GAAP) :
-Earnings: $292.3 Mln. vs. $362.1 Mln. last year. -EPS: $0.50 vs. $0.61 last year. -Revenue: $1.553 Bln vs. $1.354 Bln last year.
-Guidance: Next quarter EPS guidance: $0.58 - $0.64 Next quarter revenue guidance: $1.51 - $1.59 Bln Full year EPS guidance: $2.56 - $2.62
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Edwards Lifesciences Corp.mehr Nachrichten
Analysen zu Edwards Lifesciences Corp.mehr Analysen
Aktien in diesem Artikel
| Edwards Lifesciences Corp. | 71,18 | 0,81% |
|